SMS PHARMACEUTICALS
Back to Income Statement
|
SMS PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹783 Cr | ₹709 Cr | ₹522 Cr | ₹520 Cr | ₹563 Cr |
What is the latest Revenue of SMS PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹783 Cr |
| Mar2024 | ₹709 Cr |
| Mar2023 | ₹522 Cr |
| Mar2022 | ₹520 Cr |
| Mar2021 | ₹563 Cr |
How is Revenue of SMS PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹783 Cr | 10.36 | |
| Mar2024 | ₹709 Cr | 35.86 | |
| Mar2023 | ₹522 Cr | 0.42 | |
| Mar2022 | ₹520 Cr | -7.69 | |
| Mar2021 | ₹563 Cr | - | |
Compare Revenue of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,838.0 Cr | 8.3% | 13.8% | 76.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | 8.3% |
13.8% |
76.8% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses